OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

ADMA — ADMA Biologics, Inc.

NASDAQ

FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 6, 2025

REVENUE

$134.2M +10.0%

NET MARGIN

27.1% -0.9 PTS

EPS

$0.15 +7.1%

FREE CASH FLOW

-$1.1M -105.7%

No summary has been written for this call yet.